Early phase drug development: Assessing, predicting and formulating with delivery in mind
Development of new therapeutics demands substantial investment of time and capital, frequently with low chances of success. As a result, there is huge pressure to deliver reduced timelines and realise drug development programs. Scientists involved in development must balance opportunities to mitigate risk, and increase efficiency whilst maintaining quality. At Almac, we understand that developing therapeutics with a focus on delivery is fundamental to achieving success both in developmental phases and in the final product. What you will learn:
